Generics policies–a globally-relevant implementation challenge

Journal Title: Generics and Biosimilars Initiative Journal - Year 2012, Vol 1, Issue 3

Abstract

Vogler and Zimmerman, reporting on the 2011 Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference, have noted the incomplete application of generics policies in many settings, and have called for more consistent policies. While many of the basic building blocks of such policies are well described, some elements required renewed attention.

Authors and Affiliations

Andy Gray

Keywords

Related Articles

Recent trends and special topics in new drug review in PMDA

The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory agency, which works together with the Ministry of Health, Labour and Welfare. At the 24th Drug Information Association Annual EuroMeeting in Mar...

Introduction to the GaBI Journal

I am proud and pleased to be able to write the introduction to this first issue of the Generics and Biosimilars Initiative Journal (GaBI Journal).

Italy’s final position paper on biosimilars and new price and reimbursement pathway

The AIFA’s position paper recognizes the relevance of biosimilars to ensure the sustainability of drug expenditure but the new price and reimbursement procedure may not favour their prompt market access.

Do low- to middle-income countries need a biosimilar approval pathway based on a full comparability exercise?

Despite the fact that hepatitis C is a disease of global importance, many countries cannot afford the costly but effective combination treatment of peg-interferon and ribavirin, which was recently included in the World H...

ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities

The International Conference on Harmonisation (ICH) has endorsed a new guideline concerning the development and manufacture of chemical and biotechnological/biological drug substances. The guideline harmonises the scient...

Download PDF file
  • EP ID EP355630
  • DOI 10.5639/gabij.2012.0103-4.027
  • Views 103
  • Downloads 0

How To Cite

Andy Gray (2012). Generics policies–a globally-relevant implementation challenge. Generics and Biosimilars Initiative Journal, 1(3), 113-114. https://europub.co.uk/articles/-A-355630